InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Scienture Holdings, Inc.

SCNX Clue Score31
United States Fiscal year ends December CIK 0001382574
$3.76 -2.59% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.76 −19.66% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue2.5Operating income−1.0Net income−2.8EPS, diluted−0.09Fiscal year 2017Revenue2.9 +18.1%Operating income0.4Net income0.3EPS, diluted0.01Fiscal year 2018Revenue3.8 +30.7%Operating income−0.1Net income0.0 −96.9%EPS, diluted0.00Fiscal year 2019Revenue7.4 +94.1%Operating income0.1Net income−0.3 −3,247.0%EPS, diluted−0.05Fiscal year 2020Revenue17.1 +130.3%Operating income−2.5Net income−2.5Fiscal year 2021Revenue9.9 −42.2%Operating income−5.3Net income−5.3EPS, diluted−0.65Fiscal year 2022Revenue10.3 +3.6%Operating income−2.9Net income−3.5EPS, diluted−6.13Fiscal year 2023Revenue1.4 −86.7%Operating income−4.4Net income−17.8EPS, diluted−23.35Fiscal year 2024Revenue0.1 −90.0%Operating income−14.7Net income9.1EPS, diluted2.48Fiscal year 2025Revenue0.4 +215.9%Operating income−42.6Net income−41.5 −557.9%EPS, diluted−2.70
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.5 2.9 3.8 7.4 17.1 9.9 10.3 1.4 0.1 0.4
Growth +18.1% +30.7% +94.1% +130.3% −42.2% +3.6% −86.7% −90.0% +215.9%
Operating income −1.0 0.4 −0.1 0.1 −2.5 −5.3 −2.9 −4.4 −14.7 −42.6
Net income −2.8 0.3 0.0 −0.3 −2.5 −5.3 −3.5 −17.8 9.1 −41.5
Growth −96.9% −3,247.0% −557.9%
EPS, diluted −0.09 0.01 0.00 −0.05 n/a −0.65 −6.13 −23.35 2.48 −2.70

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin100.0%Operating margin−40.6%Net margin−111.2%Fiscal year 2017Gross margin100.0%Operating margin13.5%Net margin9.9%Fiscal year 2018Gross margin88.3%Operating margin−2.3%Net margin0.2%Fiscal year 2019Gross margin65.5%Operating margin1.7%Net margin−3.8%Fiscal year 2020Gross margin33.3%Operating margin−14.6%Net margin−14.8%Free cash flow margin−13.2%Fiscal year 2021Gross margin48.0%Operating margin−53.5%Net margin−53.8%Free cash flow margin−26.2%Fiscal year 2022Gross margin53.8%Operating margin−28.4%Net margin−33.9%Fiscal year 2023Gross margin3.6%Operating margin−322.4%Net margin−1,308.3%Fiscal year 2024Gross margin4.4%Operating margin−10,758.7%Net margin6,634.7%Free cash flow margin−10,448.6%Fiscal year 2025Gross margin76.8%Operating margin−9,867.9%Net margin−9,618.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 100.0% 100.0% 88.3% 65.5% 33.3% 48.0% 53.8% 3.6% 4.4% 76.8%
Operating margin −40.6% 13.5% −2.3% 1.7% −14.6% −53.5% −28.4% −322.4% −10,758.7% −9,867.9%
Net margin −111.2% 9.9% 0.2% −3.8% −14.8% −53.8% −33.9% −1,308.3% 6,634.7% −9,618.0%
Free cash flow margin n/a n/a n/a n/a −13.2% −26.2% n/a n/a −10,448.6% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−0.5Fiscal year 2017Operating cash flow0.2Fiscal year 2018Operating cash flow0.3Fiscal year 2019Operating cash flow0.1Fiscal year 2020Operating cash flow−2.2Capital expenditure−0.0Free cash flow−2.3Fiscal year 2021Operating cash flow−2.6Capital expenditure−0.0Free cash flow−2.6Fiscal year 2022Operating cash flow−1.5Fiscal year 2023Operating cash flow−2.2Fiscal year 2024Operating cash flow−14.3Capital expenditure−0.0Free cash flow−14.3Dividends paid−14.9Fiscal year 2025Operating cash flow−13.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.5 0.2 0.3 0.1 −2.2 −2.6 −1.5 −2.2 −14.3 −13.4
Capital expenditure n/a n/a n/a n/a −0.0 −0.0 n/a n/a −0.0 n/a
Free cash flow n/a n/a n/a n/a −2.3 −2.6 n/a n/a −14.3 n/a
Growth
Dividends paid n/a n/a n/a n/a n/a n/a n/a n/a −14.9 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.0Shareholders’ equity−1.1Fiscal year 2017Cash0.2Total debt0.7Net cash (debt)−0.5Shareholders’ equity−0.3Fiscal year 2018Cash0.9Total debt0.5Net cash (debt)0.3Shareholders’ equity0.8Debt to equity0.62Fiscal year 2019Cash2.9Total debt0.2Net cash (debt)2.6Shareholders’ equity4.1Debt to equity0.05Fiscal year 2020Cash5.9Shareholders’ equity8.7Fiscal year 2021Cash3.1Shareholders’ equity3.8Fiscal year 2022Cash1.1Shareholders’ equity0.8Fiscal year 2023Cash0.2Shareholders’ equity0.5Fiscal year 2024Cash0.3Total debt2.9Net cash (debt)−2.6Shareholders’ equity79.1Debt to equity0.04Fiscal year 2025Cash6.7Shareholders’ equity70.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.0 0.2 0.9 2.9 5.9 3.1 1.1 0.2 0.3 6.7
Total debt n/a 0.7 0.5 0.2 n/a n/a n/a n/a 2.9 n/a
Net cash (debt) n/a −0.5 0.3 2.6 n/a n/a n/a n/a −2.6 n/a
Shareholders’ equity −1.1 −0.3 0.8 4.1 8.7 3.8 0.8 0.5 79.1 70.1
Debt to equity n/a n/a 0.62 0.05 n/a n/a n/a n/a 0.04 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018† 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
2.5 2.9 3.8 7.4 17.1 9.9 10.3 1.4 0.1 0.4
Growth +18.1% +30.7% +94.1% +130.3% −42.2% +3.6% −86.7% −90.0% +215.9%
n/a n/a 0.4 2.6 11.4 5.1 4.7 1.3 0.1 0.1
2.5 2.9 3.4 4.9 5.7 4.7 5.5 0.0 0.0 0.3
Growth +18.1% +15.4% +44.0% +17.2% −16.8% +16.3% −99.1% −87.8% +5,420.1%
n/a n/a n/a n/a n/a n/a n/a n/a 2.2 2.0
3.5 2.5 3.5 4.4 7.5 1.9 1.7 1.3 6.7 7.9
−1.0 0.4 −0.1 0.1 −2.5 −5.3 −2.9 −4.4 −14.7 −42.6
Growth −122.2% −2,101.7%
n/a n/a n/a n/a n/a n/a n/a −8.5 −18.8 −43.5
n/a n/a n/a n/a n/a n/a n/a n/a −0.5 −2.0
−2.8 0.3 0.0 −0.3 −2.5 −5.3 −3.5 −17.8 9.1 −41.5
Growth −96.9% −3,247.0% −557.9%
Per share
−0.09 0.01 0.00 −0.05 n/a −0.65 −6.15 −23.35 2.69 −2.70
−0.09 0.01 0.00 −0.05 n/a −0.65 −6.13 −23.35 2.48 −2.70
Growth −100.0% −208.9%
31.5 32.0 5.4 5.9 n/a 8.1 0.6 0.8 3.4 15.3
31.5 34.1 5.8 5.9 n/a n/a 0.6 2.4 3.7 15.3
Growth +8.1% −82.9% +1.8% +320.3% +53.4% +320.1%

† The diluted share count jumps at 2018 and 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 52.1% a year over five years.
  • Operating margin is down 9,853.3 points on five years ago, at -9,867.9%.
  • A net loss in 7 of 10 years on file.